Identification of BCSCs from tumor samples and breast cancer cells relies mainly on CD44+/CD24– or ALDH phenotypes (Ginestier et al., 2007; Fillmore and Kuperwasser, 2008; Gupta et al., 2009). Here, CD44 is linked to neoplasm.